(Total Views: 485)
Posted On: 03/27/2023 11:10:50 AM
Post# of 79

$AGEN News Article - Agenus' Botensilimab in Combination with Balstilimab Shows 33% Durable Responses in Ovarian Cancer https://marketwirenews.com/news-releases/agen...42679.html
My Twitter: WhyteStocks